HomeCompareGREZF vs MRK

GREZF vs MRK: Dividend Comparison 2026

GREZF yields 3.18% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GREZF wins by $4.76M in total portfolio value
10 years
GREZF
GREZF
● Live price
3.18%
Share price
$3.16
Annual div
$0.10
5Y div CAGR
72.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.82M
Annual income
$3,808,330.89
Full GREZF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GREZF vs MRK

📍 GREZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGREZFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GREZF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GREZF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GREZF
Annual income on $10K today (after 15% tax)
$270.60/yr
After 10yr DRIP, annual income (after tax)
$3,237,081.26/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GREZF beats the other by $3,228,752.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GREZF + MRK for your $10,000?

GREZF: 50%MRK: 50%
100% MRK50/50100% GREZF
Portfolio after 10yr
$2.44M
Annual income
$1,909,064.51/yr
Blended yield
78.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GREZF
No analyst data
Altman Z
4.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GREZF buys
0
MRK buys
0
No recent congressional trades found for GREZF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGREZFMRK
Forward yield3.18%2.76%
Annual dividend / share$0.10$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR72.5%32.7%
Portfolio after 10y$4.82M$56.8K
Annual income after 10y$3,808,330.89$9,798.13
Total dividends collected$4.71M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GREZF vs MRK ($10,000, DRIP)

YearGREZF PortfolioGREZF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,249$549.16$11,206$366.19+$43.00GREZF
2$13,033$995.92$12,650$502.35+$383.00GREZF
3$15,805$1,860.11$14,407$694.19+$1.4KGREZF
4$20,548$3,636.71$16,585$967.82+$4.0KGREZF
5$29,609$7,622.37$19,342$1,363.89+$10.3KGREZF
6$49,388$17,707.03$22,913$1,947.19+$26.5KGREZF
7$100,462$47,616.37$27,662$2,823.89+$72.8KGREZF
8$263,643$156,148.78$34,159$4,173.35+$229.5KGREZF
9$942,729$660,630.80$43,337$6,308.80+$899.4KGREZF
10$4,817,051$3,808,330.89$56,776$9,798.13+$4.76MGREZF

GREZF vs MRK: Complete Analysis 2026

GREZFStock

GREE, Inc., a technology company, engages in the online media business in Japan and internationally. It operates through Internet and Entertainment, and Investment and Incubation segments. The company provides GREE, a social networking services (SNS) platform, and social games and diverse content closely linked with SNS, offering a variety of entertainment related elements centered on user-to-user communication; and develops and operates app games for smartphones under the GREE, WFS, Pokelabo, and GREE Entertainment brands to app delivery platforms. It also operates REALITY, a metaverse virtual live streaming app; REALITY XR cloud, a cloud solution for virtual events that take place in any virtual space; and REALITY STUDIO, a virtual creative label that has produced a wide variety of talent, including KMNZ, VESPERBELL, and HACHI. In addition, the company operates aumo, a travel and lifestyle information services platform; LIMIA, an on-line magazine that features home and living lifestyle content; MINE, an on-line video magazine that features women's fashion, beauty, and lifestyle topics; and ARINE, an on-line magazine for young women with the latest content on topics. Further, it provides DX support for client business based on experiences and achievements; and produces, develops, and directs anime and manga IP content. Additionally, the company invests in startup companies operating mainly in the Internet and IT fields through venture capital funds or corporate venture capital. GREE, Inc. was founded in 2004 and is headquartered in Tokyo, Japan.

Full GREZF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GREZF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GREZF vs SCHDGREZF vs JEPIGREZF vs OGREZF vs KOGREZF vs MAINGREZF vs JNJGREZF vs ABBVGREZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.